Urinary Malondialdehyde as a Biomarker of Type 2 Diabetes Mellitus Treatment in the Primary Care Unit of a Tertiary Care Hospital
Open Access
- 1 January 2021
- journal article
- research article
- Published by SAGE Publications in Journal of Primary Care & Community Health
- Vol. 12
Abstract
The examination of Urinary Malondialdehyde (UMDA) as a biomarker in the involvement of inflammatory response and oxidative stress, as a mechanism underlying the development of diabetes; in addition to complications in followed-up patients at a primary healthcare unit. The level of UMDA and its related factors in T2DM patients, between good and poor glycemic control was investigated. This analytical cross-sectional study was conducted at the primary care unit, of Songklanagarind Hospital; from May 2020 to August 2020. The voluntary patients were divided into 2 groups, by using a percentage of HbA1c ≤7% as a good control T2DM group, and higher than 7% as a poor control T2DM group. The comparison statistics and logistic regression analysis were performed by using R Program. A total of 71 patients voluntarily participated in this study, and consisted of: 38 patients with poor glycemic control and 33 patients with good glycemic control. There were no significant differences between the patients; with the exception of smoking habits. The average levels of UMDA of the good control group (2.43 ± 0.91 μg/mL) were slightly lower than the poor control group (2.60 ± 0.96 μg/mL): P-value >.05. Patients who had underlying diseases, smoking, or drinking habits displayed significantly different levels of UMDA. Being a non-smoking patients, and having a higher level of HDL-C with significant protective factors, while having increased level of FBS and triglyceride were pointedly negative factors of oxidative stress status. Patients who had good control of T2DM produced better health outcomes than the poor control group. UMDA, FBS, HDL-C, and triglyceride levels could be applied as follow-up criteria in T2DM patients within a primary healthcare setting.Keywords
Funding Information
- Prince of Songkla University (MED620183M)
This publication has 14 references indexed in Scilit:
- Macrophage Migration Inhibitory Factor and Malondialdehyde as Potential Predictors of Vascular Risk Complications in Type 2 Diabetes Mellitus: Cross-Sectional Case Control Study in Saudi ArabiaMediators of Inflammation, 2016
- Dietary and lifestyle determinants of malondialdehyde DNA adducts in a representative sample of the Florence City populationMutagenesis, 2016
- Urinary Malondialdehyde Is Associated with Visceral Abdominal Obesity in Middle‐Aged MenMediators of Inflammation, 2015
- Hyperglycemia-induced Oxidative Stress and its Role in Diabetes Mellitus Related Cardiovascular DiseasesCurrent Pharmaceutical Design, 2013
- Dyslipidemia Associated with Poor Glycemic Control in Type 2 Diabetes Mellitus and the Protective Effect of Metformin SupplementationIndian Journal of Clinical Biochemistry, 2012
- Oxidative Stress and Glycaemic Control in Type 2 Diabetic Patients in Enugu, South-East Nigeria2011
- Lipid and lipoprotein profiles in Ethiopian patients with diabetes mellitusMetabolism, 2006
- Biomarkers of Oxidative Damage in Human DiseaseClinical Chemistry, 2006
- Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemiaInternational Journal Of Clinical Practice, 2006
- The Relationship of Glycemic Exposure (HbA1c) to the Risk of Development and Progression of Retinopathy in the Diabetes Control and Complications TrialDiabetes, 1995